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Abstract The outer membrane (OM) vitamin B12 receptor,
BtuB, is the primary receptor for E group colicin adsorption
to Escherichia coli. Cell death by this family of toxins requires
the OM porin OmpF but its role remains elusive. We show that
OmpF enhances the ability of puri¢ed BtuB to protect bacteria
against the endonuclease colicin E9, demonstrating either that
the two OM proteins form the functional receptor or that OmpF
is recruited for subsequent translocation of the bacteriocin.
While stable binary colicin E9^BtuB complexes could be readily
shown in vitro, OmpF-containing complexes could not be de-
tected, implying that OmpF association with the BtuB^colicin
complex, while necessary, must be weak and/or transient in
nature.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In the continual battle for survival in nutrient-limited envi-
ronments, Gram-negative bacteria such as Escherichia coli
frequently release potent toxins that can selectively eliminate
competing bacterial strains but not producing cells [1,2].
Prominent amongst these toxins are colicins, plasmid-encoded
protein antibiotics induced via the SOS response. Colicins
have evolved to parasitise various cell surface receptors that
are normally involved in the uptake and passage of small
nutrient molecules, such as iron complexes [3], vitamin B12
[4] and nucleosides [5], across the outer cell membrane. The
importance of colicins to bacterial colonisation is evident
from the diverse range of microorganisms where similar toxins
have been identi¢ed, including Salmonella typhimurium, Pseu-
domonas aeruginosa, Klebsiella pneumoniae, Photorhabdus lu-
minescens, Shigella £exneri, Yersinia pestis and Serratia mar-
cescens.
Colicins are classi¢ed according to the cell surface receptor
to which they bind [6]. The E colicins (colicins E1^E9) and
colicin A adsorb to a minor component of the outer mem-
brane (OM) ^ the 66 kDa BtuB receptor protein ^ which is an
essential element of the high-a⁄nity uptake system for coba-
lamin (vitamin B12) in E. coli [7]. It is of interest to note that
while all BtuB receptors in the OM have the ability to trans-
port vitamin B12, only a few appear to facilitate colicin action
[8]. Translocation of colicins across the cell envelope to their
target is poorly understood, but known to be mediated by a
group of membrane and periplasmic proteins ^ the Tol [9] and
Ton [10] systems. Cell death by group A colicins (which in-
clude colicins A, N and E1^E9) [11] requires the porin OmpF
and the Tol system (composed of TolA, B, Q and R proteins),
whereas group B colicins (B, D, Ia, M and V) require the Ton
system [12]. Both Ton and Tol proteins are responsive to the
proton motive force across the inner membrane which, in the
case of the Ton system, is responsible for energy-dependent
transport of metabolites across the OM [13].
The lethal action of E colicins on susceptible E. coli cells
requires three events: receptor binding, membrane transloca-
tion, and cytotoxicity (reviewed in [2]). Three functional do-
mains of the E colicin proteins have been implicated in each
stage of the killing process [14]. Receptor binding occurs via
the central ‘R’ domain, translocation is mediated via the
N-terminal ‘T’ domain, and cytotoxic activity is centred on
the carboxy-terminal ‘C’ domain [2,15]. The toxic e¡ects of
group A colicins can be ascribed to one of three activities:
colicins A and E1 form pores in the cytoplasmic membrane
resulting in collapse of membrane potential (reviewed in [16]);
colicins E2, E7, E8 and E9 each possess DNase activity [2,17];
and colicins E3, E4, E5 and E6 are all RNases [2,18]. Colicin-
producing bacteria arm themselves against suicide through the
co-synthesis of a small (6 10 kDa) immunity protein that
binds and neutralises the cytotoxic domain with high a⁄nity
[2,19]. In the case of 60 kDa enzymatic colicins, the immunity
protein associates with the toxin in the producing organism,
the heterodimeric complex is then released into the extracel-
lular medium and the immunity protein jettisoned upon ad-
sorption of the colicin complex to its primary receptor [20].
Previous, sometimes contradictory, work on the susceptibil-
ity of bacteria toward E group colicins has suggested that
adsorption of the toxin requires the presence of monomeric
BtuB and the trimeric, major OM protein OmpF [21,22]. Us-
ing the pore-forming colicin A in cell killing assays, Chai et al.
[22] implicated OmpF, BtuB and lipopolysaccharide (LPS) as
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the functional colicin A receptor. Subsequent work by Bene-
detti et al. [21] compared the binding of colicins A, E2 and E3
and suggested that OmpF alone was required for both recep-
tor binding and translocation of colicin A, whereas an inter-
mediate situation existed for the enzymatic colicins E2 and E3
where only BtuB acted as receptor but both BtuB and OmpF
(along with the Tol system) were required for translocation
[21].
To our knowledge there are currently no in vitro data on
the role of OmpF in the uptake of E group colicins. We
present the ¢rst in vitro analysis using puri¢ed proteins, show-
ing that OmpF in concert with BtuB is likely involved in
forming the functional OM conduit for E group colicins.
2. Materials and methods
2.1. Plasmids, bacterial strains and growth conditions
Wild-type BtuB was overexpressed in the porin-de¢cient E. coli
strain TNE012 (K12 tsx3ompA3ompB3) [23,24] from plasmid
pNP278. Polymerase chain reaction mutagenesis was used to intro-
duce an NcoI restriction site after the signal sequence of BtuB and an
XhoI restriction site immediately downstream of the stop codon. The
1.8 kb product, ampli¢ed from the template pAG1, was cloned into
the SmaI restriction site of pUC18 to produce pNP271. Plasmid
pNP271 was digested with NcoI and XhoI, and the BtuB gene minus
its signal sequence was cloned into complementary sites of pBAD
mycC HisB (Invitrogen) to form the recombinant plasmid, pNP278,
that was under the tight control of the arabinose inducible promoter.
BtuB synthesis was induced by addition of 0.15% (w/v) L-(+)-ara-
binose to growing cultures at 37‡C with shaking in Luria^Bertani
(LB) broth supplemented with 100 Wg ml31 ampicillin at an OD600
of 0.4^0.6. After induction, cells were grown to an OD600 of V1.5,
then harvested by centrifugation and lyophilised to dryness. Lyophi-
lised cells were stored at 320‡C until further use.
E. coli strain BE3000 cells were used as a source of OmpF porin
[26]. These cells were grown at 37‡C with shaking to an OD600 of
V1.3 in LB broth supplemented with 0.25% (w/v) D-glucose, then
harvested by centrifugation and stored at 320‡C until required.
Overproduction of colicin E9, growth of colicin-sensitive JM83 cells
for use in cell protection assays and construction of colicin E9 T-R
domain has been described elsewhere [27,28].
2.2. Protein puri¢cation
BtuB was puri¢ed using a protocol modi¢ed from that described by
Jalal and van der Helm [29] for puri¢cation of the FepA receptor
protein. 0.5 g of lyophilised E. coli TNE012(pNP278) cells (equivalent
to V1.5 l of cell culture) was resuspended in 70 ml of bu¡er A (10
mM Tris^HCl, pH 8.0, 0.25% lithium diiodosalicylate (LIS) and pro-
tease inhibitor cocktail tablets (Roche Diagnostics)), then sonicated
on ice. The sonicated cells were centrifuged at 8000Ug for 10 min at
4‡C to pellet any unbroken cells and cell debris. The supernatant was
retained and centrifuged for 1 h at 200kUg. To solubilise the inner
membrane protein fraction, the resulting pellet was resuspended and
homogenised inV56 ml of bu¡er B (bu¡er A and 2% Triton X-100),
stirred at room temperature for 30 min and centrifuged again at
200kUg for 1 h at 20‡C. To ensure that all the inner membrane
proteins were solubilised, the extraction with bu¡er B was repeated.
BtuB was solubilised by extracting the pellet three times with bu¡er C
(bu¡er B and 5 mM EDTA, pH 8.0), then a further two times with
bu¡er D (bu¡er C and 1% (w/v) n-octyl-L-D-glucopyranoside (OG)
(Melford Chemicals)). The ¢ve BtuB-containing supernatants (from
extractions with bu¡ers C and D) were pooled and dialysed overnight
at room temperature against 3 l of bu¡er E (50 mM Tris^HCl, pH
7.5, 0.25% LIS, 2% Triton X-100 and 5 mM EDTA) using 25 kDa
MWCO membrane (Spectrum Laboratories).
After dialysis the protein solution was loaded onto a 50 ml DE-52
(Whatman) anion exchange column that had been equilibrated in
bu¡er E. After a 50 ml wash, the protein was eluted with a 0^800
mM NaCl gradient. The collected fractions were analysed by sodium
dodecyl sulphate^polyacrylamide gel electrophoresis (SDS^PAGE)
(12.5% polyacrylamide) using a Hoefer Mighty Small gel apparatus
and the BtuB-containing fractions pooled and dialysed overnight
against 3 l of 50 mM Tris, pH 7.5, 5 mM EDTA, 0.05% LIS and
2% Triton X-100 using 25 kDa MWCO dialysis membrane.
Detergent exchange and LIS removal were achieved by loading the
dialysed protein solution onto a 10 ml DE-52 anion exchange column
equilibrated with 100 ml of bu¡er F (50 mM Tris, pH 7.5, 5 mM
EDTA, 1% (w/v) OG). The protein was washed with 50 ml of bu¡er F
and eluted with a 0^800 mM NaCl gradient. Fractions containing
BtuB were pooled, desalted and concentrated to V2 ml using Cen-
triprep YM-50 centrifugal ¢ltration devices (Millipore). The protein
was exchanged into 15 mM NaH2PO4, pH 7.5, 1% (w/v) OG by
passage down a Sephadex G-15 (Pharmacia) gel ¢ltration column.
OmpF porin was puri¢ed from E. coli BE3000 cells as reported by
Nikaido [26]. Puri¢cation of free colicin E9 (colicin with the immunity
protein removed) and colicin E9 T-R has been described previously
[27,28].
2.3. Protein determinations
BtuB and trimeric OmpF concentrations were determined spectro-
scopically on a Unicam 8625 UV^vis spectrometer using theoretical
extinction coe⁄cients (calculated using the ExPASy programme Prot-
Param tool) at 280 nm of 136 690 and 145 500 M31 cm31, respec-
tively. The Bradford colorimetric assay was used to determine colicin
E9 and colicin E9 T-R domain concentrations.
2.4. Characterisation of BtuB
The secondary structure content of the puri¢ed BtuB receptor was
characterised by far UV-CD (circular dichroism) spectroscopy (260^
190 nm) on an Applied Photophysics Z* spectropolarimeter using a
0.1 cm quartz cuvette and a protein concentration of 0.05 mg ml31 (in
15 mM NaH2PO4, pH 7.5, 1% (w/v) OG). The spectrum was mea-
sured using 1 nm steps with a 25 Ws sampling period and both ex-
citation and emission slits were set to 2.0 nm. All measurements were
conducted at 20‡C under constant nitrogen £ush. The secondary
structure content of puri¢ed BtuB was calculated using the deconvo-
lution software CDNN version 2.1 (http://bioinformatik.biochem
tech.uni-halle.de/cdnn/).
Conformation of the receptor was evaluated qualitatively by di¡er-
ential migration ( V heating of samples) on SDS^PAGE using a Phast-
Gel system (Pharmacia) essentially as described by Taylor et al. [24].
The ability of puri¢ed BtuB to bind vitamin B12 was assayed by
applying the puri¢ed protein to a 2 ml column of vitamin B12 immo-
bilised on 4% beaded agarose (Sigma Chemical). 500 Wl of a 1.2 mg
ml31 solution of BtuB was applied to the column which had previ-
ously been equilibrated with 15 mM NaH2PO4, pH 7.5, 1% (w/v)
L-OG. The column was then washed extensively with the same bu¡-
er/detergent solution to remove any unbound receptor. Bound recep-
tor was eluted with a 4 mg ml31 vitamin B12 solution and fractions
analysed using a 12% SDS^PAGE gel.
2.5. Cell protection assays
Cell protection assays were performed essentially as described by
Wallis et al. [30] but with some modi¢cations. 80 Wl of colicin-suscep-
tible E. coli JM83 cells in mid-log phase was added to 50 ml of 0.7%
(w/v) molten micro-agar (Duchefa) at 42‡C and used to overlay a 243
mmU243 mmU18 mm square plate containing LB agar supple-
mented with 100 Wg ml31 ampicillin. After drying, 6 Wl spots of
2.5 nM free colicin E9 (2 Wl of 7.5 nM colicin E9 and 4 Wl 15 mM
NaH2PO4, pH 7.5, 0.85% (w/v) OG) were applied to one lane of the
plate as a control. Subsequently, colicin E9 was incubated for 30 min
at room temperature with either bovine serum albumin (BSA), BtuB
or OmpF (2 Wl of 7.5 nM colicin E9, 2 Wl receptor and 2 Wl bu¡er) and
then spotted onto the relevant lanes of the assay plate. The ¢nal
receptor concentrations were varied from 125 nM to 1.25 WM to
give a range of receptor:colicin E9 from 50:1 to 500:1. The experi-
ment was repeated using equimolar concentrations of BtuB and
OmpF or BtuB and BSA. The plate was then incubated overnight
at 37‡C.
2.6. Gel ¢ltration and cross-linking experiments
Complex formation between the receptors BtuB and OmpF, and
free colicin E9 or colicin E9 T-R domain were assayed using size-
exclusion chromatography and chemical cross-linking experiments.
Colicin E9 T-R domain was chosen as the ligand for the gel ¢ltration
experiments because (i) it has an Mr that is su⁄ciently di¡erent from
that of either OmpF or BtuB, thereby increasing the resolution of the
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gel ¢ltration assay, and (ii) it has been previously shown to bind to
BtuB-expressing cells [28].
A pre-packed Sephacryl S-300 HiPrep 16/60 column (Pharmacia)
was connected to a Pharmacia FPLC system and equilibrated with
15 mM NaH2PO4, pH 7.5, 150 mM NaCl and 1% (w/v) OG at a £ow
rate of 0.5 ml min31. Samples of the proteins to be assayed were
prepared for chromatography by dialysing them extensively against
the same bu¡er. For each analytical run the ¢nal concentration of
each protein component was adjusted to 10 WM in a volume of 100 Wl.
Solutions containing more than one protein component were pre-in-
cubated at room temperature for 30 min prior to application to the
column.
Cross-linking used both lipophilic and aqueous cross-linkers and
included ethylene glycobis(succinimidylsuccinate) (Pierce), sulfo-
EGS, 1-ethyl-3-[3-(dimethylamino)propyl] (Pierce), glutaraldehyde
(Sigma Chemical) and the photoreactive cross-linker Tris(2,2P-bipyr-
ydyl)dichlororuthenium(II)hexahydrate (Ru(bpy)3Cl2) (Aldrich). Typ-
ically, reactions were carried out in a total volume of 20 Wl consisting
of 10 WM protein (in 15 mM NaH2PO4, pH 7.5, 150 mM NaCl, 1%
(w/v) OG) and cross-linker at a ¢nal concentration of 3 mM. The
reaction was allowed to proceed for 30 min at 25‡C prior to quench-
ing by addition of Tris^HCl, pH 7.5, to a ¢nal concentration of
50 mM. After quenching, the reaction mixtures were analysed by
SDS^PAGE using pre-cast 4^20% acrylamide gradient gels (Gradi-
pore) and protein bands were visualised by staining with Coomassie
blue. In the case of Ru(bpy)3Cl2 and glutaraldehyde, cross-linking
experiments were carried out according to the methods of Fancy
and Kodadek [31] and Margosiak et al. [32], respectively.
3. Results and discussion
3.1. Puri¢cation and characterisation of BtuB
The puri¢cation of BtuB has been described previously [23^
25]. After several unsuccessful attempts at the ¢rst reported
puri¢cation of recombinant BtuB [24], which in our hands
gave very low yields of protein, we developed a puri¢cation
scheme based on that used for the iron siderophore porin
FepA [29] (see Section 2). Our puri¢cation scheme also uti-
lised a novel overexpression construct in which the btub gene
was placed under the control of an arabinose-inducible pro-
moter and shown previously to produce functional BtuB on
E. coli cell surfaces [28]. The far UV-CD spectrum of OG-
solubilised BtuB receptor puri¢ed by this protocol is shown in
Fig. 1a. BtuB contains 22 L-strands based on its primary se-
quence similarity with other large OM porins such as FepA,
FecA and Cir, and con¢rmed by the recently published struc-
ture for BtuB [33]. Analysis of the CD of spectrum of puri¢ed
BtuB (see Section 2) indicated the presence ofV51% L-sheet,
in good agreement with the crystallographically determined
L-structure content of FhuA [34] and FepA [35] receptors
but di¡erent from that reported by the earlier study of Taylor
et al. for BtuB [24]. Comparison with the amount of L-sheet
determined from the structure of BtuB itself awaits release of
the pdb coordinates. We assessed the functional status of our
puri¢ed BtuB preparations using anomalous migration in
SDS gels (native BtuB is resistant to SDS-induced denatura-
tion [24]) and its ability to bind to a vitamin B12 column (Fig.
1b,c). These indicated that our puri¢ed BtuB was natively
folded and functionally active.
3.2. OmpF enhances the ability of BtuB to protect cells against
colicin E9
Direct involvement of OmpF in E colicin uptake has been
inferred but not shown directly. Therefore, to investigate any
interactions between the receptors and/or E colicins, cell pro-
tection assays were performed using the DNase colicin E9 pre-
incubated with BtuB, OmpF, and BtuB in the presence of
OmpF. As can be seen in Fig. 2, colicin E9 pre-incubated
with BtuB resulted in complete cell protection being conferred
at a BtuB:colicin E9 ratio ofV400:1. This is in contrast with
the results obtained by Taylor et al. [24], who reported pro-
tection of susceptible cells from the e¡ects of the RNase co-
licin E3 when the puri¢ed receptor was present in only modest
stoichiometric excess. The reasons for this disparity may lie in
the di¡erent ways the cell protection assays were conducted,
di¡ering strain sensitivities and/or the di¡erent cytotoxic ac-
tivities of the colicins used.
In the presence of equimolar quantities of OmpF with re-
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Fig. 1. a: Far UV-CD spectrum of puri¢ed BtuB in 15 mM
NaH2PO4, pH 7.5, 1% (w/v) OG. b: Homogeneous 12.5% Phastgel
SDS^PAGE showing anomalous migration of native BtuB. Lane 1,
molecular weight markers; lanes 2 and 3, unheated BtuB (apparent
MrV45 kDa); lane 4, heat-treated BtuB (which migrates at its true
Mr of V66 kDa). c: 12% SDS^PAGE gel showing fractions eluted
from a vitamin B12 agarose column. The ¢rst lane contains molecu-
lar weight markers. The second lane shows the BtuB load. The fol-
lowing two lanes represent the £owthrough from the column and
the fractions from the wash step, respectively. BtuB receptor eluted
when the column was washed with an excess of vitamin B12 solu-
tion.
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hanced (Fig. 2, lane e). In this case complete protection was
conferred at a BtuB/OmpF:colicin E9 ratio ofV200:1. How-
ever, as was the case with BtuB incubated with colicin E9,
there is a degree of protection conferred at a BtuB/OmpF:co-
licin E9 ratio of 50:1. This is the ¢rst direct evidence that
OmpF acts synergistically with BtuB in binding of an enzy-
matic colicin. To determine if this was speci¢c to OmpF, BtuB
was pre-incubated with BSA as a negative control (Fig. 2, lane
f). In this case no enhancement of cell protection was ob-
served. This indicates that protein concentration alone was
not responsible for the observed enhancement of protection
when OmpF was present with BtuB. Hence it seems that the
protection a¡orded by OmpF is due to a speci¢c interaction(s)
between OmpF and BtuB or an interaction that is mediated
by the colicin.
Previous studies that have suggested OmpF is an important
component of the OM receptor for colicin A also suggested
that LPS is involved [22]. In our studies, addition of exoge-
nous LPS from E. coli K-235 to the receptors produced no
change in cell protection (data not shown). However, these
and the earlier experiments do not preclude any role for
LPS tightly bound to either BtuB (which is known to co-
purify with LPS [24,25]) or OmpF. Therefore, the issue of
LPS involvement will require closer scrutiny.
3.3. OmpF associates only weakly or transiently with a
BtuB^colicin E9 complex
Since the cell protection assays had shown OmpF enhanced
the protection a¡orded by BtuB against colicin E9 toxicity we
sought more direct methods of establishing the presence of
higher-order complexes, focusing on gel-¢ltration chromatog-
raphy and chemical cross-linking. For these experiments we
used both full-length colicin E9 (from which its immunity
protein had been removed) and a truncated version called
colicin E9 T-R in which the C-terminal, 15 kDa DNase do-
main had been deleted. Colicin E9 T-R has previously been
shown to bind as e¡ectively to BtuB-expressing E. coli cells as
intact colicin E9 [28], and was used here because its lower
molecular weight (47 kDa) allowed for ready assignment of
proteins on accompanying gels and column pro¢les.
Gel ¢ltration chromatography was performed using 10 WM
protein solutions in 15 mM NaH2PO4, pH 7.5, 150 mM NaCl
and 1% (w/v) OG. Individual proteins eluted as single species,
their elution volumes corresponding to their relative di¡eren-
ces in molecular mass. Fig. 3 shows that OmpF trimer
(Mr = 111 000 Da) eluted at a volume of 59 ml (Fig. 3d), the
66 325 Da BtuB receptor eluted at 65.3 ml (Fig. 3a), and
colicin E9 T-R eluted at 70.6 ml (Fig. 3b).
Pre-incubation of stoichiometric amounts of BtuB with co-
licin E9 T-R prior to loading onto the column resulted in a
major peak that eluted at 58 ml (Fig. 3c). SDS^PAGE re-
vealed that this peak was a BtuB^colicin E9 T-R complex,
with essentially identical results obtained for full-length coli-
cin E9 (data not shown). When BtuB was pre-incubated with
OmpF and the sample ran on the column no stable complex
was formed, con¢rmed by SDS^PAGE analysis of the col-
lected peak fractions (data not shown). Pre-incubation of co-
licin E9 T-R with a solution of BtuB and OmpF (to give a
1:1:1 stoichiometry) did not result in a supershift of the
BtuB^colicin E9 T-R complex (expected Mr of V248 000
Da) but merely resulted in a peak eluting at 59.5 ml, close
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Fig. 2. Plate assay showing the enhancement of protection of susceptible E. coli cells provided by BtuB in the presence of OmpF. In all the
lanes, colicin E9 was present at a ¢nal concentration of 2.5 nM. At this concentration large clear zones, indicating cell death, are visible (lane
a). The presence of BSA or OmpF with colicin E9 did not o¡er any cell protection, indicating that OmpF alone did not bind the colicin (lanes
b and d, respectively). Lane c shows the protective e¡ects of BtuB. The same pattern of protection was observed in lane f, in which BSA was
present along with BtuB and colicin E9. However, when BtuB was added to colicin E9 in the presence of OmpF cell protection was greatly en-
hanced (lane e). All protein solutions were prepared in 15 mM NaH2PO4, pH 7.5, 0.85% (w/v) OG.
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Chemical cross-linking, using a range of lipophilic and
aqueous cross-linking agents (see Section 2), was also used
to analyse higher-order complexes. Complexes of colicin E9
and its immunity protein Im9, and BtuB^colicin E9, as well as
dimers and trimers of OmpF could be detected in control
experiments (data not shown). However, no cross-linked ad-
ducts containing both OmpF and BtuB (or BtuB^colicin E9)
could be found, which along with the absence of stable com-
plexes on gel-¢ltration suggests that any interaction between
OmpF and the BtuB^colicin E9 complex must be weak or
transient in nature or perhaps requires stabilisation by anoth-
er component of the pathway.
3.4. Conclusions
Very little has previously been published on the role of
OmpF in E group colicin adsorption although studies have
suggested a role for this receptor in cell killing [21,22].
Through cell protection assays we demonstrate for the ¢rst
time that OmpF acts synergistically with BtuB to protect bac-
teria against the action of colicin E9. This interaction could
indicate that OmpF is a component of the receptor apparatus
for the colicin. Alternatively, OmpF could be recruited by the
colicin following its initial docking to BtuB, in which case its
role may have more to do with translocation than receptor
recognition, as has been suggested by Benedetti et al. [21].
Whichever interpretation is correct, it is clear that the associ-
ation of OmpF with the BtuB-colicin binary complex is likely
to be weak and transient, as witnessed by our failure to detect
tertiary complexes either by gel ¢ltration or chemical cross-
linking. Having now established an in vitro system incorpo-
rating BtuB and OmpF, future work will focus on dissecting
the roles of LPS and Tol proteins in colicin uptake that may
eventually lead to reconstitution of an intact colicin ‘trans-
locon’.
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BtuB-TR complex + OmpF
Fig. 3. Gel ¢ltration chromatography was used to monitor complex
formation between the BtuB and OmpF receptors, and colicin E9
T-R domain. All protein solutions were prepared in 15 mM
NaH2PO4, pH 7.5, 150 mM NaCl, 1% (w/v) OG. BtuB eluted at
65.3 ml (panel a), and colicin E9 T-R construct (panel b) and
OmpF alone (panel d) eluted at 70.6 ml and 59.2 ml, respectively.
Complex formation between BtuB and colicin E9 T-R (10 WM of
each protein) could be observed by the presence of a 58.3 ml elution
peak (panel c). Under the conditions employed in this assay, no
complex formation between BtuB and OmpF, OmpF and colicin E9
T-R domain (data not shown), or BtuB^colicin E9 T-R complex
and OmpF (panel e), could be observed.
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